You have 9 free searches left this month | to do more
Showing 1 - 25 of
250 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Cologne, Germany
    University of Cologne
2021-08-17
Aug 17, 2021
M
Daratumumab to Treat Active Lupus Nephritis
Recruiting
  • Lupus Nephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-05-19
May 19, 2021
W
Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
Not yet recruiting
  • Glioblastoma
  • Daratumumab
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
2021-06-25
Jun 25, 2021
M
Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease
Recruiting
  • Alzheimer Disease
  • Daratumumab Injection
  • Manhasset, New York
    The Litwin-Zucker Research Center
2021-11-16
Nov 16, 2021
D
The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia
Not yet recruiting
  • Hemolytic Anemia
  • Daratumumab / Hyaluronidase Injection
  • (no location specified)
2021-10-13
Oct 13, 2021
U
Treatment of POEMS Syndrome With Daratumumab
Recruiting
  • POEMS Syndrome
  • Daratumumab Injection
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
2021-08-02
Aug 2, 2021
A
Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy
Not yet recruiting
  • Multiple Myeloma
  • Lenalidomide Pill
  • +2 more
  • (no location specified)
2021-06-02
Jun 2, 2021
A
Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
Not yet recruiting
  • Plasma Cell Leukemia
  • Daratumumab
  • (no location specified)
2021-09-22
Sep 22, 2021
P
Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis
Recruiting
  • Amyloidosis; Systemic
  • Daratumumab
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
2021-05-31
May 31, 2021
S
Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-10-05
Oct 5, 2021
J
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-09-07
Sep 7, 2021
M
Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-10-01
Oct 1, 2021
B
Daratumumab for the Treatment of Patients With AL Amyloidosis - 2020
Completed
Has Results
  • AL Amyloidosis
  • daratumumab
  • Boston, Massachusetts
    Boston Medical Center
2021-04-15
Apr 15, 2021
I
Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis
Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
2021-06-23
Jun 23, 2021
J
Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma
Active, not recruiting
Has Results
  • Multiple Myeloma
  • Part 1 (Dose Escalation): Daratumumab
  • +3 more
  • Boston, Massachusetts
  • +7 more
2021-11-04
Nov 4, 2021
F
Daratumumab in Treatment of PGNMID and C3 GN - 2020
Completed
Has Results
  • Membranoproliferative Glomerulonephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic
2021-06-28
Jun 28, 2021
C
Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2021-11-01
Nov 1, 2021
H
Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Daratumumab Injection
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer & Research Institute
2021-10-11
Oct 11, 2021
M
Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma
Suspended
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2021-09-27
Sep 27, 2021
P
MagnetisMM-5: Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Hamamatsu, Shizuoka, Japan
  • +9 more
2021-11-12
Nov 12, 2021
R
Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation
Withdrawn
  • Allosensitization
  • Heart Transplant Failure and Rejection
  • Daratumumab
  • (no location specified)
2020-10-26
Oct 26, 2020
W
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021
J
Pre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) Daratumumab
Approved for marketing
    • Daratumumab
    • (no location specified)
    2020-07-03
    Jul 3, 2020
    W
    Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
    Recruiting
    • Amyloid
    • +2 more
    • Daratumumab
    • +2 more
    • Palo Alto, California
    • +3 more
    2021-06-23
    Jun 23, 2021
    O
    The DART Study- Daratumumab Treatment in ITP
    Recruiting
    • ITP
    • Daratumumab Injection
    • Odense, Denmark
    • +5 more
    2021-08-24
    Aug 24, 2021